genOway Société anonyme Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	23.53	23.75	21.54	18.36	15.79
Other Revenue	5.07	3.78	5.39	2.89	4
Revenue	28.6	27.53	26.93	21.25	19.79
Revenue Growth (YoY)	3.88%	2.23%	26.73%	7.38%	21.30%
Cost of Revenue	13.27	12.81	10.67	9.3	9.39
Gross Profit	15.33	14.73	16.26	11.95	10.4
Selling, General & Admin	10.37	10.24	9.2	8.04	8.22
Other Operating Expenses	0.28	0.17	0.24	0.76	0.95
Operating Expenses	14.06	13.38	13.84	11.32	11.1
Operating Income	1.27	1.34	2.41	0.63	-0.7
Interest Expense	-0.31	-0.15	-	-0.49	-0.27
Interest & Investment Income	0.03	0.26	0.04	0.17	0.25
Currency Exchange Gain (Loss)	0.02	0.38	-	-	-
EBT Excluding Unusual Items	1.02	1.84	2.45	0.31	-0.72
Gain (Loss) on Sale of Investments	0.09	0.08	-	-	-
Gain (Loss) on Sale of Assets	-0.18	-0.42	-0.9	-	-
Other Unusual Items	-	0.31	0	0.45	0.37
Pretax Income	0.92	1.81	1.55	0.76	-0.35
Income Tax Expense	-0.01	-0.02	-0.02	-0.02	-0.03
Net Income	0.93	1.83	1.57	0.78	-0.32
Net Income to Common	0.93	1.83	1.57	0.78	-0.32
Net Income Growth	-49.32%	16.79%	101.55%	-	-
Free Cash Flow	-9.78	4.75	-	-	-
Gross Margin	53.60%	53.49%	60.37%	56.24%	52.56%
Operating Margin	4.45%	4.87%	8.96%	2.97%	-3.53%
Profit Margin	3.24%	6.65%	5.82%	3.66%	-1.63%
Free Cash Flow Margin	-34.18%	17.26%	-	-	-
EBITDA	4.43	4.31	6.81	3.15	0.52
EBITDA Margin	15.48%	15.66%	25.28%	14.82%	2.64%
D&A For EBITDA	3.15	2.97	4.4	2.52	1.22
EBIT	1.27	1.34	2.41	0.63	-0.7
EBIT Margin	4.45%	4.87%	8.96%	2.97%	-3.53%
Revenue as Reported	28.56	27.66	26.59	21.4	19.8